Guselkumab 100 mg Every 8 Weeks Consistently Improves Joint, Skin Through Week 24
The COSMOS trial showed guselkumab every 8 weeks improved PsA outcomes through week 48, including in patients with inadequate responses to TNF inhibitors.
Related Articles
Public Health Experts Decry Louisiana’s Ban on Vaccine Promotion
Doctors need to ‘stand up’ for their patients’ health, they say
Facing death differently: revolutionising our approach to death and grief
Despite growing public interest in death, support for end-of-life care and bereavement remains inadequate. We urgently need a community centred, public health approach to the…
ĹŚURA Snags $200M, Hits $5.2B Valuation – MedCity News
Fidelity Management & Research Company and Dexcom participated in ŌURA’s $200 million Series D round.
Blast Injuries | NEJM
This video focuses on the mechanisms and classifications of blast injuries seen in war, terrorist attacks, and accidents and presents essential knowledge for initial diagnosis…
Zavegepant to Treat Migraine Attacks Amongst Those Using Preventive Medication
Learn more about services at Mayo Clinic.
MD-Granting Medical Schools in the US, 2023-2024
This Appendix presents data derived from the 2023-2024 Liaison Committee on Medical Education Annual Medical School Questionnaire-Part II.
Prevention With Joel Kahn, MD
Dr. Kahn is a summa cum laude graduate of the University of Michigan School of Medicine. He practices cardiology in Detroit, is a clinical professor…
Headway in Hepatology: Resmetirom’s Historic FDA Approval, What’s Next in MASH
Resmetirom made history when it became the first and only FDA-approved MASH drug in 2024, but the pipeline continues to show promise heading into 2025.
I used Apple Image Playground to send AI holiday greetings to my whole family and they were very confused
Apple Intelligence is wonderful and strange
Good nights: optimising children’s health through bedtime stories
Fairy tales offer opportunities to engage with children about healthy and disordered sleep, say Megan Thomas and colleagues Healthy sleep is a public health priority,…